For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Physician-directed Postoperative Activity Restriction | Postoperative activity restrictions prescribed by physician. Postoperative activity restrictions: Recommendations for return to full activity including return to school, sports, exercise, etc. | 0 | None | 0 | 20 | 2 | 20 | View |
| Self-directed Postoperative Activity Restriction | Postoperative activity restrictions self-determined (parent/guardian and/or patient). Postoperative activity restrictions: Recommendations for return to full activity including return to school, sports, exercise, etc. | 0 | None | 0 | 62 | 5 | 62 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| infection requiring antibiotics | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| skin inflammation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| anesthesia reaction | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| urinary tract infection | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| drug rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |